semaglutide nursing While Breastfeeding: Safety & You might've heard of this

Anderson, FASAE, CAE, IOM President & Chief Executive Officer Date: June 4, 2026 Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide

Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer

Discover why GLP-1 weight loss medications are most effective when your hormones are balanced, and how Affinity Whole Health can help you achieve optimal results.

Discover how GLP-1 agonists in transplant patients can safely manage post-transplant diabetes and weight gain

Head-to-head post-registration trial or a real-world data study would be helpful

A medically guided approach designed to boost energy and metabolic balance.